SoniVie For Profit
SoniVie's lead product, TIVUS, is an investigational intravascular treatment that can be performed as part of a routine right heart catheterization for patients suffering from pulmonary arterial hypertension (PAH)
Founded Date:
2014-01-01
Headquarters:
Rosh Ha'ayin, HaMerkaz, Israel
Technology:
Biomarker panels
Employee Number:
11-50
Industry:
Clinical Data Management